REPORTS

Let’s Pullulate and Expand Your Business

Global Non-prescription Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Feb 27, 2020  |  192 PAGES  |  REPORT CODE: CMM269042
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Non-prescription Drugs is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period. The research provides insights for the global Non-prescription Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Non-prescription Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Non-prescription Drugs Market Segmentations:

By Players:

  • Takeda

  • Allergan

  • Sanofi

  • GlaxoSmithKline (GSK)

  • Bristol-Myers Squibb

  • Merck & Co. (MSD)

  • Gilead Sciences

  • Shire

  • Amgen

  • AbbVie

  • Novartis

  • Bayer

  • Novo Nordisk

  • Roche

  • Boehringer Ingelheim

  • Eli Lilly

  • Pfizer

  • Teva

  • Johnson & Johnson

  • AstraZeneca

By Types:

  • Brand Drugs

  • Generic Drug

By End-User:

  • Hospital

  • Clinic

  • Other

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Non-prescription Drugs Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Non-prescription Drugs Market Share by Types

    • 1.3.2 Global Non-prescription Drugs Market Size and Growth Rate of Brand Drugs from 2014 to 2026

    • 1.3.3 Global Non-prescription Drugs Market Size and Growth Rate of Generic Drug from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Non-prescription Drugs Market Share by End-Users

    • 1.4.2 Global Non-prescription Drugs Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Global Non-prescription Drugs Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.4 Global Non-prescription Drugs Market Size and Growth Rate of Other from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Non-prescription Drugs Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Non-prescription Drugs Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Non-prescription Drugs by Major Types

    • 3.4.1 Market Size and Growth Rate of Brand Drugs

    • 3.4.2 Market Size and Growth Rate of Generic Drug

4 Segmentation of Non-prescription Drugs Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Non-prescription Drugs by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Non-prescription Drugs for Hospital

    • 4.4.2 Market Size and Growth Rate of Non-prescription Drugs for Clinic

    • 4.4.3 Market Size and Growth Rate of Non-prescription Drugs for Other

5 Market Analysis by Major Regions

  • 5.1 Global Non-prescription Drugs Production Analysis by Major Regions

  • 5.2 Global Non-prescription Drugs Consumption Analysis by Major Regions

  • 5.3 Global Non-prescription Drugs Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Non-prescription Drugs Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Non-prescription Drugs Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Non-prescription Drugs Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Non-prescription Drugs Production, Import, Consumption and Export Analysis

6 Product Commodity of Non-prescription Drugs Market in Major Countries

  • 6.1 Top 5 Export Countries in Non-prescription Drugs market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Non-prescription Drugs market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Non-prescription Drugs market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Non-prescription Drugs market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Non-prescription Drugs market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Non-prescription Drugs market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Non-prescription Drugs Landscape Analysis

  • 7.1 North America Non-prescription Drugs Landscape Analysis by Major Types

  • 7.2 North America Non-prescription Drugs Landscape Analysis by Major End-Users

  • 7.3 North America Non-prescription Drugs Landscape Analysis by Major Countries

    • 7.3.1 United States Non-prescription Drugs Market Volume and Growth Rate

    • 7.3.2 Canada Non-prescription Drugs Market Volume and Growth Rate

    • 7.3.3 Mexico Non-prescription Drugs Market Volume and Growth Rate

8 Europe Non-prescription Drugs Landscape Analysis

  • 8.1 Europe Non-prescription Drugs Landscape Analysis by Major Types

  • 8.2 Europe Non-prescription Drugs Landscape Analysis by Major End-Users

  • 8.3 Europe Non-prescription Drugs Landscape Analysis by Major Countries

    • 8.3.1 Germany Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.2 UK Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.3 France Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.4 Italy Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.6 Spain Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.7 Belgium Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.8 Poland Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.9 Russia Non-prescription Drugs Market Volume and Growth Rate

    • 8.3.10 Turkey Non-prescription Drugs Market Volume and Growth Rate

9 Asia Pacific Non-prescription Drugs Landscape Analysis

  • 9.1 Asia Pacific Non-prescription Drugs Landscape Analysis by Major Types

  • 9.2 Asia Pacific Non-prescription Drugs Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Non-prescription Drugs Landscape Analysis by Major Countries

    • 9.3.1 China Non-prescription Drugs Market Volume and Growth Rate

    • 9.3.2 Japan Non-prescription Drugs Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Non-prescription Drugs Market Volume and Growth Rate

    • 9.3.4 India Non-prescription Drugs Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Non-prescription Drugs Market Volume and Growth Rate

    • 9.3.6 South Korea Non-prescription Drugs Market Volume and Growth Rate

10 Latin America, Middle East & Africa Non-prescription Drugs Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Non-prescription Drugs Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Non-prescription Drugs Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Non-prescription Drugs Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Non-prescription Drugs Market Volume and Growth Rate

    • 10.3.2 Brazil Non-prescription Drugs Market Volume and Growth Rate

    • 10.3.3 Nigeria Non-prescription Drugs Market Volume and Growth Rate

    • 10.3.4 South Africa Non-prescription Drugs Market Volume and Growth Rate 

    • 10.3.5 Argentina Non-prescription Drugs Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Takeda

    • 11.1.1 Takeda Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Allergan

    • 11.2.1 Allergan Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Sanofi

    • 11.3.1 Sanofi Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 GlaxoSmithKline (GSK)

    • 11.4.1 GlaxoSmithKline (GSK) Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Bristol-Myers Squibb

    • 11.5.1 Bristol-Myers Squibb Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Merck & Co. (MSD)

    • 11.6.1 Merck & Co. (MSD) Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Gilead Sciences

    • 11.7.1 Gilead Sciences Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Shire

    • 11.8.1 Shire Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Amgen

    • 11.9.1 Amgen Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 AbbVie

    • 11.10.1 AbbVie Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Novartis

    • 11.11.1 Novartis Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Bayer

    • 11.12.1 Bayer Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 Novo Nordisk

    • 11.13.1 Novo Nordisk Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Roche

    • 11.14.1 Roche Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Boehringer Ingelheim

    • 11.15.1 Boehringer Ingelheim Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 Eli Lilly

    • 11.16.1 Eli Lilly Company Profile and Development Status

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

  • 11.17 Pfizer

    • 11.17.1 Pfizer Company Profile and Development Status

    • 11.17.2 Market Performance

    • 11.17.3 Product and Service Introduction

  • 11.18 Teva

    • 11.18.1 Teva Company Profile and Development Status

    • 11.18.2 Market Performance

    • 11.18.3 Product and Service Introduction

  • 11.19 Johnson & Johnson

    • 11.19.1 Johnson & Johnson Company Profile and Development Status

    • 11.19.2 Market Performance

    • 11.19.3 Product and Service Introduction

  • 11.20 AstraZeneca

    • 11.20.1 AstraZeneca Company Profile and Development Status

    • 11.20.2 Market Performance

    • 11.20.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 92 Figures and 144 Tables)

  • Figure Product Picture

  • Figure Global Non-prescription Drugs Market Size and Growth Rate of Brand Drugs from 2014 to 2026

  • Figure Global Non-prescription Drugs Market Size and Growth Rate of Generic Drug from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Non-prescription Drugs Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Non-prescription Drugs Market Size and Growth Rate of Clinic from 2014 to 2026

  • Figure Global Non-prescription Drugs Market Size and Growth Rate of Other from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Non-prescription Drugs Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Non-prescription Drugs Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Non-prescription Drugs

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Non-prescription Drugs by Different Types from 2014 to 2026

  • Table Consumption Share of Non-prescription Drugs by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Brand Drugs

  • Figure Market Size and Growth Rate of Generic Drug

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Non-prescription Drugs by Different End-Users from 2014 to 2026

  • Table Consumption Share of Non-prescription Drugs by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Clinic

  • Figure Market Size and Growth Rate of Other

  • Table Global Non-prescription Drugs Production by Major Regions

  • Table Global Non-prescription Drugs Production Share by Major Regions

  • Figure Global Non-prescription Drugs Production Share by Major Regions in 2014

  • Figure Global Non-prescription Drugs Production Share by Major Regions in 2018

  • Figure Global Non-prescription Drugs Production Share by Major Regions in 2026

  • Table Global Non-prescription Drugs Consumption by Major Regions

  • Table Global Non-prescription Drugs Consumption Share by Major Regions

  • Figure Global Non-prescription Drugs Consumption Share by Major Regions in 2014

  • Figure Global Non-prescription Drugs Consumption Share by Major Regions in 2018

  • Figure Global Non-prescription Drugs Consumption Share by Major Regions in 2026

  • Table North America Non-prescription Drugs Production, Import, Consumption and Export Analysis

  • Table Europe Non-prescription Drugs Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Non-prescription Drugs Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Non-prescription Drugs Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Non-prescription Drugs market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Non-prescription Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Non-prescription Drugs market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Non-prescription Drugs market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Non-prescription Drugs Consumption by Types from 2014 to 2026

  • Table North America Non-prescription Drugs Consumption Share by Types from 2014 to 2026

  • Figure North America Non-prescription Drugs Consumption Share by Types in 2014

  • Figure North America Non-prescription Drugs Consumption Share by Types in 2018

  • Figure North America Non-prescription Drugs Consumption Share by Types in 2026

  • Table North America Non-prescription Drugs Consumption by End-Users from 2014 to 2026

  • Table North America Non-prescription Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure North America Non-prescription Drugs Consumption Share by End-Users in 2014

  • Figure North America Non-prescription Drugs Consumption Share by End-Users in 2018

  • Figure North America Non-prescription Drugs Consumption Share by End-Users in 2026

  • Table North America Non-prescription Drugs Consumption by Major Countries from 2014 to 2026

  • Table North America Non-prescription Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Non-prescription Drugs Consumption Share by Major Countries in 2014

  • Figure North America Non-prescription Drugs Consumption Share by Major Countries in 2018

  • Figure North America Non-prescription Drugs Consumption Share by Major Countries in 2026

  • Figure United States Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Non-prescription Drugs Consumption by Types from 2014 to 2026

  • Table Europe Non-prescription Drugs Consumption Share by Types from 2014 to 2026

  • Figure Europe Non-prescription Drugs Consumption Share by Types in 2014

  • Figure Europe Non-prescription Drugs Consumption Share by Types in 2018

  • Figure Europe Non-prescription Drugs Consumption Share by Types in 2026

  • Table Europe Non-prescription Drugs Consumption by End-Users from 2014 to 2026

  • Table Europe Non-prescription Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Non-prescription Drugs Consumption Share by End-Users in 2014

  • Figure Europe Non-prescription Drugs Consumption Share by End-Users in 2018

  • Figure Europe Non-prescription Drugs Consumption Share by End-Users in 2026

  • Table Europe Non-prescription Drugs Consumption by Major Countries from 2014 to 2026

  • Table Europe Non-prescription Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Non-prescription Drugs Consumption Share by Major Countries in 2014

  • Figure Europe Non-prescription Drugs Consumption Share by Major Countries in 2018

  • Figure Europe Non-prescription Drugs Consumption Share by Major Countries in 2026

  • Figure Germany Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure France Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Non-prescription Drugs Consumption by Types from 2014 to 2026

  • Table Asia Pacific Non-prescription Drugs Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by Types in 2014

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by Types in 2018

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by Types in 2026

  • Table Asia Pacific Non-prescription Drugs Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Non-prescription Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by End-Users in 2014

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by End-Users in 2018

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by End-Users in 2026

  • Table Asia Pacific Non-prescription Drugs Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Non-prescription Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Non-prescription Drugs Consumption Share by Major Countries in 2026

  • Figure China Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandNon-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure India Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-prescription Drugs Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Non-prescription Drugs Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Non-prescription Drugs Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Non-prescription Drugs Consumption Share by Major Countries in 2026

  • Figure GCC Countries Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Non-prescription Drugs Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Takeda

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

  • Figure Sales and Growth Rate Analysis of Takeda

  • Figure Revenue and Market Share Analysis of Takeda

  • Table Product and Service Introduction of Takeda

  • Table Company Profile and Development Status of Allergan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

  • Figure Sales and Growth Rate Analysis of Allergan

  • Figure Revenue and Market Share Analysis of Allergan

  • Table Product and Service Introduction of Allergan

  • Table Company Profile and Development Status of Sanofi

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

  • Figure Sales and Growth Rate Analysis of Sanofi

  • Figure Revenue and Market Share Analysis of Sanofi

  • Table Product and Service Introduction of Sanofi

  • Table Company Profile and Development Status of GlaxoSmithKline (GSK)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline (GSK)

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline (GSK)

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline (GSK)

  • Table Product and Service Introduction of GlaxoSmithKline (GSK)

  • Table Company Profile and Development Status of Bristol-Myers Squibb

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

  • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

  • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

  • Table Product and Service Introduction of Bristol-Myers Squibb

  • Table Company Profile and Development Status of Merck & Co. (MSD)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co. (MSD)

  • Figure Sales and Growth Rate Analysis of Merck & Co. (MSD)

  • Figure Revenue and Market Share Analysis of Merck & Co. (MSD)

  • Table Product and Service Introduction of Merck & Co. (MSD)

  • Table Company Profile and Development Status of Gilead Sciences

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences

  • Figure Sales and Growth Rate Analysis of Gilead Sciences

  • Figure Revenue and Market Share Analysis of Gilead Sciences

  • Table Product and Service Introduction of Gilead Sciences

  • Table Company Profile and Development Status of Shire

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

  • Figure Sales and Growth Rate Analysis of Shire

  • Figure Revenue and Market Share Analysis of Shire

  • Table Product and Service Introduction of Shire

  • Table Company Profile and Development Status of Amgen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

  • Figure Sales and Growth Rate Analysis of Amgen

  • Figure Revenue and Market Share Analysis of Amgen

  • Table Product and Service Introduction of Amgen

  • Table Company Profile and Development Status of AbbVie

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

  • Figure Sales and Growth Rate Analysis of AbbVie

  • Figure Revenue and Market Share Analysis of AbbVie

  • Table Product and Service Introduction of AbbVie

  • Table Company Profile and Development Status of Novartis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

  • Figure Sales and Growth Rate Analysis of Novartis

  • Figure Revenue and Market Share Analysis of Novartis

  • Table Product and Service Introduction of Novartis

  • Table Company Profile and Development Status of Bayer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

  • Figure Sales and Growth Rate Analysis of Bayer

  • Figure Revenue and Market Share Analysis of Bayer

  • Table Product and Service Introduction of Bayer

  • Table Company Profile and Development Status of Novo Nordisk

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

  • Figure Sales and Growth Rate Analysis of Novo Nordisk

  • Figure Revenue and Market Share Analysis of Novo Nordisk

  • Table Product and Service Introduction of Novo Nordisk

  • Table Company Profile and Development Status of Roche

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

  • Figure Sales and Growth Rate Analysis of Roche

  • Figure Revenue and Market Share Analysis of Roche

  • Table Product and Service Introduction of Roche

  • Table Company Profile and Development Status of Boehringer Ingelheim

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

  • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

  • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

  • Table Product and Service Introduction of Boehringer Ingelheim

  • Table Company Profile and Development Status of Eli Lilly

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

  • Figure Sales and Growth Rate Analysis of Eli Lilly

  • Figure Revenue and Market Share Analysis of Eli Lilly

  • Table Product and Service Introduction of Eli Lilly

  • Table Company Profile and Development Status of Pfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

  • Figure Sales and Growth Rate Analysis of Pfizer

  • Figure Revenue and Market Share Analysis of Pfizer

  • Table Product and Service Introduction of Pfizer

  • Table Company Profile and Development Status of Teva

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

  • Figure Sales and Growth Rate Analysis of Teva

  • Figure Revenue and Market Share Analysis of Teva

  • Table Product and Service Introduction of Teva

  • Table Company Profile and Development Status of Johnson & Johnson

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson

  • Figure Revenue and Market Share Analysis of Johnson & Johnson

  • Table Product and Service Introduction of Johnson & Johnson

  • Table Company Profile and Development Status of AstraZeneca

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

  • Figure Sales and Growth Rate Analysis of AstraZeneca

  • Figure Revenue and Market Share Analysis of AstraZeneca

  • Table Product and Service Introduction of AstraZeneca


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top